Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.175    0.00 (0.00%)
Bid:
0.17
Ask:
0.18
Spread: 0.01 (5.882%)
Market Cap: £2.31m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Holding(s) in Company

3 Aug 2020 14:49

RNS Number : 9761U
ValiRx PLC
03 August 2020
Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Valirx PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Monecor (London) Limited

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

31/07/2020

6. Date on which issuer notified (DD/MM/YYYY):

03/08/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.413

-

6.413

54,062,373

Position of previous notification (if

applicable)

8.86

8.86

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

GB00BLH13C52

Β 

3,466,989

-

6.413

-

SUBTOTAL 8. A

3,466,989

6.413

Β 

Β 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

Β 

Β 

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Β 

Place of completion

London, UK

Date of completion

03/08/2020

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
HOLUOSORRWUWRAR
Date   Source Headline
31st Aug 20227:00 amRNSHalf-year Report
17th Aug 20227:00 amRNSShareholder Communications
14th Jul 202210:46 amRNSHolding(s) in Company
13th Jul 20222:15 pmRNSSuccessful evaluation of breast cancer programme
7th Jul 202211:07 amRNSDirector/PDMR Shareholding
5th Jul 202211:45 amRNSHolding(s) in Company
5th Jul 20227:00 amRNSBroker Option Results
30th Jun 20223:00 pmRNSResult of AGM and Appointment of Joint Broker
30th Jun 202210:31 amRNSIssue of Equity
30th Jun 202210:30 amRNSExtends exclusivity period for TheoremRx
17th Jun 202210:01 amRNSUpdate on VAL201 sub-license agreement
7th Jun 20224:33 pmRNSAnnual Report, AGM Notice & Director Resignation
23rd Mar 20227:00 amRNSUpdate on proposed sub-license of VAL201
15th Mar 20227:00 amRNSOperational and Strategy Update
14th Feb 20227:00 amRNSEvaluation agreement with University of Barcelona
5th Jan 20224:41 pmRNSSecond Price Monitoring Extn
5th Jan 20224:36 pmRNSPrice Monitoring Extension
5th Jan 20222:06 pmRNSSecond Price Monitoring Extn
5th Jan 20222:00 pmRNSPrice Monitoring Extension
5th Jan 202211:00 amRNSPrice Monitoring Extension
5th Jan 20229:06 amRNSSecond Price Monitoring Extn
5th Jan 20229:00 amRNSPrice Monitoring Extension
5th Jan 20227:16 amRNSSigns Service Agreement with TheoremRx
20th Dec 20217:00 amRNSAmends License for VAL201 with CRT
16th Dec 202110:46 amRNSEvaluation agreement with Hokkaido University
11th Nov 20217:00 amRNSLive Shareholder Q&A and Investor presentations
8th Nov 20213:03 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSigns Letter of Intent to Sub-License VAL201
26th Oct 20212:00 pmRNSPrice Monitoring Extension
26th Oct 202111:05 amRNSSecond Price Monitoring Extn
26th Oct 202111:00 amRNSPrice Monitoring Extension
26th Oct 20217:00 amRNSHolding(s) in Company
20th Oct 20211:19 pmRNSHolding(s) in Company
19th Oct 202112:23 pmRNSHolding(s) in Company
18th Oct 20214:41 pmRNSSecond Price Monitoring Extn
18th Oct 20214:36 pmRNSPrice Monitoring Extension
18th Oct 20212:06 pmRNSSecond Price Monitoring Extn
18th Oct 20212:01 pmRNSPrice Monitoring Extension
18th Oct 202111:06 amRNSSecond Price Monitoring Extn
18th Oct 202111:00 amRNSPrice Monitoring Extension
30th Sep 20212:45 pmRNSHolding(s) in Company
30th Sep 202112:24 pmRNSHolding(s) in Company
28th Sep 20214:41 pmRNSSecond Price Monitoring Extn
28th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20214:41 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
16th Sep 20217:00 amRNSNew Evaluation Agreement
8th Sep 20217:00 amRNSHolding(s) in Company
7th Sep 20217:00 amRNSHalf-year Report
25th Aug 20217:00 amRNSAppointment of Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.